Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.3748 ◽

2015 ◽

Vol 24 (4) ◽

pp. 406-413 ◽

Author(s):

Sascha Abbas ◽

Peter Ihle ◽

Sebastian Harder ◽

Ingrid Schubert

Keyword(s):

Heart Failure ◽

Angiotensin Receptor Blocker ◽

Ace Inhibitor ◽

Real Life ◽

Angiotensin Receptor ◽

Blocker Therapy ◽

Life Data ◽

Real Life Data ◽

Download Full-text

Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease

American Heart Journal ◽

10.1016/j.ahj.2016.03.024 ◽

2016 ◽

Vol 178 ◽

pp. 28-36 ◽

Author(s):

Hanna Fröhlich ◽

Christoph Nelges ◽

Tobias Täger ◽

Vedat Schwenger ◽

Rita Cebola ◽

...

Keyword(s):

Heart Failure ◽

Chronic Kidney Disease ◽

Renal Function ◽

Kidney Disease ◽

Angiotensin Receptor Blocker ◽

Ace Inhibitor ◽

Angiotensin Receptor ◽

Patients With Heart Failure ◽

Long Term Changes

Download Full-text

Abstract #601 Mortality; Major Adverse Cardiovascular Events (Mace) and Weight are Reduced in 400 Hypogonadal Men on Long-Term Testosterone Therapy (TTH) Compared to 376 Untreated Hypogonadal Controls: Real-Life Data from A 10-Year Registry

Endocrine Practice ◽

10.1016/s1530-891x(20)47240-4 ◽

2018 ◽

Vol 24 ◽

pp. 143

Author(s):

Farid Saad ◽

Ahmad Haider ◽

Karim Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Cardiovascular Events ◽

Real Life ◽

Major Adverse Cardiovascular Events ◽

Testosterone Therapy ◽

Life Data ◽

Download Full-text

Abstract #1216 Improvement of Blood Pressure (Bp); Heart Rate and Other Hemodynamic Markers in Hypogonadal Patients with Hypertension Receiving Long-Term Testosterone Therapy (Tth) Compared to Untreated Hypogonadal Controls: Real-Life Data from a 10-Year Registry

Endocrine Practice ◽

10.1016/s1530-891x(20)47508-1 ◽

2018 ◽

Vol 24 ◽

pp. 312-313

Author(s):

Farid Saad ◽

Ahmad Haider ◽

Karim Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Blood Pressure ◽

Real Life ◽

Testosterone Therapy ◽

Life Data ◽

Download Full-text

121 LONG-TERM EFFICACY AND SAFETY OF TRANS - URETHRAL NEEDLE ABLATION (TUNA ®) IN OVER 500 MEN WITH LUTS/BPH: THE EAU REAL-LIFE DATA REGISTRY

European Urology Supplements ◽

10.1016/s1569-9056(11)60124-3 ◽

2011 ◽

Vol 10 (2) ◽

pp. 63

Author(s):

A. Tubaro ◽

K. Höfner ◽

H. Villavicencio ◽

La Rosette J.J. De ◽

C.R. Chapple

Keyword(s):

Real Life ◽

Efficacy And Safety ◽

Life Data ◽

Term Efficacy ◽

Data Registry ◽

Download Full-text

Effects of Combination of ACE Inhibitor and Angiotensin Receptor Blocker on Cardiac Remodeling, Cardiac Function, and Survival in Rat Heart Failure

Circulation ◽

10.1161/01.cir.103.1.148 ◽

2001 ◽

Vol 103 (1) ◽

pp. 148-154 ◽

Author(s):

Shokei Kim ◽

Minoru Yoshiyama ◽

Yasukatsu Izumi ◽

Hitomi Kawano ◽

Manabu Kimoto ◽

...

Keyword(s):

Heart Failure ◽

Cardiac Function ◽

Cardiac Remodeling ◽

Rat Heart ◽

Angiotensin Receptor Blocker ◽

Ace Inhibitor ◽

Receptor Blocker ◽

Angiotensin Receptor

Download Full-text

MP91-11 POSITIVE EFFECTS OF LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) ON RENAL FUNCTION IN HYPOGONADAL MEN: REAL-LIFE DATA FROM A PROSPECTIVE CONTROLLED REGISTRY STUDY

The Journal of Urology ◽

10.1016/j.juro.2017.02.2851 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Aksam Yassin ◽

Dany-Jan Yassin ◽

Gheorge Doros ◽

Abdulmaged Traish

Keyword(s):

Renal Function ◽

Real Life ◽

Term Treatment ◽

Registry Study ◽

Testosterone Undecanoate ◽

Positive Effects ◽

Life Data ◽

Real Life Data ◽

Long Term Treatment

Download Full-text

Substantial weight loss in 237 hypogonadal men with obesity class I-III under long-term treatment with testosterone undecanoate (TU): Observational real-life data from a registry study

Journal of Obesity & Weight loss Therapy ◽

10.4172/2165-7904.s1.015 ◽

2015 ◽

Vol 05 (04) ◽

Author(s):

Farid Saad

Keyword(s):

Weight Loss ◽

Real Life ◽

Term Treatment ◽

Registry Study ◽

Testosterone Undecanoate ◽

Obesity Class ◽

Life Data ◽

Real Life Data ◽

Long Term Treatment

Download Full-text

Congestive heart failure: Change in risk factors, comorbidity and age at the time of first hospitalization. Follow-up of a population cohort between 2011 and 2016 using real life data

Revue d Épidémiologie et de Santé Publique ◽

10.1016/j.respe.2018.05.202 ◽

2018 ◽

Vol 66 ◽

pp. S314

Author(s):

F. Aizpuru ◽

E. Millan ◽

I. Garmendia ◽

M. Mateos ◽

J. Librero

Keyword(s):

Risk Factors ◽

Heart Failure ◽

Congestive Heart Failure ◽

Real Life ◽

Life Data ◽

Population Cohort ◽

Download Full-text

Long-Term (7 Years) Experience of Nintedanib in IPF Patients in Crete: A Real Life Data Study

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2402 ◽

2020 ◽

Author(s):

K. Antoniou ◽

E. Tsitoura ◽

A. Trachalaki ◽

E. Vasarmidi ◽

G. Margaritopoulos ◽

...

Keyword(s):

Real Life ◽

Life Data ◽

Download Full-text

Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry

BioMed Research International ◽

10.1155/2014/416892 ◽

2014 ◽

Vol 2014 ◽

pp. 1-8 ◽

Author(s):

Matteo Filippini ◽

Chiara Bazzani ◽

Fabiola Atzeni ◽

Piercarlo Sarzi Puttini ◽

Antonio Marchesoni ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Marked Improvement ◽

Real Life ◽

Tnf Alpha ◽

Life Data ◽

Highly Active ◽

Real Life Data ◽

This study involving 1033 patients with RA confirms the effectiveness of etanercept, adalimumab, and infliximab in reducing RA-related disability even in patients with a history of highly active and longstanding RA. Moreover, we found that the improvement in disability was biphasic, with a marked improvement during the first year of anti-TNF therapy, followed by slower but significant recovery over the subsequent four years.

Download Full-text